drug

Hihg-doseNRT, Low-dose NRT, bupropion

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Yu-Li Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
NCT00495352Phase 4Completed

KOLs & investigators

1
Tsuo-Hung Lan, MD, Ph.D

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Yu-Li Hospital
company
trial
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Tobacco Dependence
indication
Tobacco Use Disorder
indication
KOL
Tsuo-Hung Lan, MD, Ph.D
KOL score —
person